Format

Send to

Choose Destination
Nat Commun. 2018 Jan 9;9(1):125. doi: 10.1038/s41467-017-02624-8.

Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses.

Author information

1
Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.
2
Immunotherapeutics Branch, Research Institute, National Cancer Center, Goyang, 10408, South Korea.
3
Immunotherapeutics Branch, Research Institute, National Cancer Center, Goyang, 10408, South Korea. swlee1905@ncc.re.kr.
4
Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea. bypark@yonsei.ac.kr.

Abstract

Human cytomegalovirus (HCMV) has evolved sophisticated immune evasion mechanisms that target both the innate and adaptive immune responses. However, how HCMV encoded proteins are involved in this immune escape is not clear. Here, we show that HCMV glycoprotein US9 inhibits the IFN-β response by targeting the mitochondrial antiviral-signaling protein (MAVS) and stimulator of interferon genes (STING)-mediated signaling pathways. US9 accumulation in mitochondria attenuates the mitochondrial membrane potential, leading to promotion of MAVS leakage from the mitochondria. Furthermore, US9 disrupts STING oligomerization and STING-TBK1 association through competitive interaction. Intriguingly, US9 blocks interferon regulatory factor 3 (IRF3) nuclear translocation and its cytoplasmic domain is essential for inhibiting IRF3 activation. Mutant HCMV lacking US7-16 is impaired in antagonism of MAVS/STING-mediated IFN-β expression, an effect that is reversible by the introduction of US9. Our findings indicate that HCMV US9 is an antagonist of IFN signaling to persistently evade host innate antiviral responses.

PMID:
29317664
PMCID:
PMC5760629
DOI:
10.1038/s41467-017-02624-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center